SCHEMBL6175236

SCHEMBL6175236

Cc1cccc2c(CC3(C)NC(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C3=O)ccnc12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.50
AR P10275 5/20 0.36
KMT2A Q03164 2/20 0.35
TP53 P04637 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
EGLN3 Q9H6Z9 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
THRB P10828 1/20 0.32
HTR1A P08908 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31
MBOAT4 Q96T53 1/20 0.31
ITGAL P20701 1/20 0.31
NAMPT P43490 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173468 0.90 IGF1R (0.49) IGF1RARKMT2ATP53PTGDR2
SCHEMBL6176094 0.90 IGF1R (0.49) IGF1RARKMT2ATP53THRB
SCHEMBL6171503 0.87 IGF1R (0.65) IGF1RARKMT2ATP53PTGDR2
SCHEMBL6175292 0.87 IGF1R (0.65) IGF1RARKMT2ATP53PTGDR2
SCHEMBL6172368 0.86 IGF1R (0.52) IGF1RARKMT2ATP53EGLN1
SCHEMBL6172285 0.85 MAPK7 (0.39) IGF1RARHTR1AADRA1DADRA1A
Trifluoroacetic Acid SCHEMBL17558350 0.83 IGF1R (0.60) IGF1RARKMT2APTGDR2SMN1; SMN2
Trifluoroacetic Acid SCHEMBL17558459 0.83 IGF1R (0.60) IGF1RARKMT2APTGDR2SMN1; SMN2
SCHEMBL6174186 0.83 IGF1R (0.51) IGF1RARKMT2ATP53SMN1; SMN2
SCHEMBL6175170 0.81 IGF1R (0.44) IGF1RARKMT2ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed